Helicobacter pylori urease and thiol-containing bacterial proteins

Helicobacter pylori urease is a critical nickel-dependent metalloenzyme that allows the bacterium to survive the highly acidic environment of the human stomach by catalyzing the hydrolysis of urea into ammonia and carbon dioxide (Mobley et al., 1995). This process raises the local pH, facilitating colonization and subsequent pathogenesis, including gastritis and peptic ulcers. The thiol-containing aspect refers to the presence of essential cysteine residues within urease and other vital bacterial proteins that are critical for enzymatic activity and redox balance. Therapeutic agents such as bismuth compounds target these thiol groups, forming stable metal-thiolate complexes that inhibit urease and disrupt various metabolic pathways (Ge & Sun, 2007). This multi-target mechanism is particularly effective because it impairs the bacterium's ability to colonize the gastric mucosa and maintain cellular homeostasis. Consequently, these targets are central to the treatment of H. pylori-associated conditions, including chronic gastritis and peptic ulcer disease (Malfertheiner et al., 2017). Monitoring treatment efficacy often involves measuring urease activity through non-invasive breath tests or biopsy-based assays.

Other names

Urea amidohydrolaseH. pylori ureaseSulfhydryl-containing bacterial enzymesThiol-dependent bacterial proteins

Inhibition of urease and other bacterial enzymes via coordinative or covalent binding to essential thiol (sulfhydryl) groups, preventing acid neutralization and disrupting bacterial metabolism.